What type of study is this?

This is a Pre-Registered Trial study.

December 8, 2025Blood

Patient perspectives on the burden of hypereosinophilic syndrome: Results from the Phase 3 natron interview sub-study

View Full Paper

Ask AI

Bookmark

Authors

Qualitative interviews reveal impacts of hypereosinophilic syndrome on quality of life and fatigue, indicating urgent treatment needs.

Patients with hypereosinophilic syndrome reported significant impacts on health-related quality of life and fatigue.
Interviews highlighted experiences with 60 symptoms across various domains including musculoskeletal and neurological issues.
The analysis involved qualitative interviews in a Phase 3 trial assessing benralizumab for hypereosinophilic syndrome.
These findings point to the urgent need for targeted interventions and improved diagnostic pathways for patients.

Ogbogu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark